Oral allopurinol to prevent hyperamylasemia and acute pancreatitis after endoscopic retrograde cholangiopancreatography.

@article{MartinezTorres2009OralAT,
  title={Oral allopurinol to prevent hyperamylasemia and acute pancreatitis after endoscopic retrograde cholangiopancreatography.},
  author={Hector Martinez-Torres and Xochilt Rodriguez-Lomeli and Carlos D{\'a}valos-Cobi{\'a}n and Jes{\'u}s E Garc{\'i}a-Correa and Juan Manuel Maldonado-Martinez and Fabiola Medrano-M{\'u}noz and Clotilde Fuentes-Orozco and Alejandro Gonz{\'a}lez-Ojeda},
  journal={World journal of gastroenterology},
  year={2009},
  volume={15 13},
  pages={1600-6}
}
AIM To assess the efficacy of allopurinol to prevent hyperamylasemia and pancreatitis after endoscopic retrograde cholangiopancreatography (PEP). METHODS One hundred and seventy patients were enrolled and randomized to two groups: a study group (n = 85) who received 300 mg of oral allopurinol at 15 h and 3 h before endoscopic retrograde cholangiopancreatography (ERCP) and a control group (n = 85) receiving an oral placebo at the same times. Main Outcome Measurements included serum amylase… CONTINUE READING